BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 26448478)

  • 1. The inferior impact of antibody-mediated rejection on the clinical outcome of kidney allografts that develop de novo thrombotic microangiopathy.
    Wu K; Budde K; Schmidt D; Neumayer HH; Lehner L; Bamoulid J; Rudolph B
    Clin Transplant; 2016 Feb; 30(2):105-17. PubMed ID: 26448478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol Biopsies in Patients With Subclinical De Novo Donor-specific Antibodies After Kidney Transplantation: A Multicentric Study.
    Bertrand D; Gatault P; Jauréguy M; Garrouste C; Sayegh J; Bouvier N; Caillard S; Lanfranco L; Galinier A; Laurent C; Etienne I; Farce F; François A; Guerrot D
    Transplantation; 2020 Aug; 104(8):1726-1737. PubMed ID: 32732853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients.
    Koppula S; Yost SE; Sussman A; Bracamonte ER; Kaplan B
    Clin Transplant; 2013; 27(4):591-7. PubMed ID: 23923969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-mediated rejection implies a poor prognosis in kidney transplantation: Results from a single center.
    Ciancio G; Gaynor JJ; Guerra G; Sageshima J; Roth D; Chen L; Kupin W; Mattiazzi A; Tueros L; Ruiz P; Vianna R; Burke GW
    Clin Transplant; 2018 Oct; 32(10):e13392. PubMed ID: 30152116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic microangiopathy in a renal allograft: Single-center five-year experience.
    Vanikar AV; Kanodia KV; Suthar KS; Nigam LA; Patel RD; Thakkar UG; Mehta AH
    Saudi J Kidney Dis Transpl; 2020; 31(6):1331-1343. PubMed ID: 33565445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Older kidney transplant patients experience less antibody-mediated rejection: a retrospective study of patients with mild to moderate sensitization.
    Scalea JR; Redfield RR; Muth BL; Mohamed M; Wilson NA; Ellis TM; Kaufman DB; Djamali A
    Clin Transplant; 2015 Dec; 29(12):1090-7. PubMed ID: 26361077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
    Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing transplant glomerulopathy in the absence of C4d deposition and donor-specific antibodies to chronic antibody-mediated rejection.
    Torres IB; Salcedo M; Moreso F; Sellarés J; Castellá E; Azancot MA; Perelló M; Cantarell C; Serón D
    Clin Transplant; 2014 Oct; 28(10):1148-54. PubMed ID: 25103874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.
    Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E
    Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
    Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Value of Protocol Biopsies to Identify Patients With De Novo Donor-Specific Antibody at High Risk for Allograft Loss.
    Schinstock CA; Cosio F; Cheungpasitporn W; Dadhania DM; Everly MJ; Samaniego-Picota MD; Cornell L; Stegall MD
    Am J Transplant; 2017 Jun; 17(6):1574-1584. PubMed ID: 27977905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation and Outcomes of C4d-Negative Antibody-Mediated Rejection After Kidney Transplantation.
    Orandi BJ; Alachkar N; Kraus ES; Naqvi F; Lonze BE; Lees L; Van Arendonk KJ; Wickliffe C; Bagnasco SM; Zachary AA; Segev DL; Montgomery RA
    Am J Transplant; 2016 Jan; 16(1):213-20. PubMed ID: 26317487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Relationship of the Severity and Category of Acute Rejection With Intimal Arteritis Defined in Banff Classification to Clinical Outcomes.
    Wu K; Budde K; Schmidt D; Neumayer HH; Rudolph B
    Transplantation; 2015 Aug; 99(8):e105-14. PubMed ID: 25719260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection.
    Satoskar AA; Pelletier R; Adams P; Nadasdy GM; Brodsky S; Pesavento T; Henry M; Nadasdy T
    Am J Transplant; 2010 Aug; 10(8):1804-11. PubMed ID: 20659088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic microangiopathy and peritubular capillary C4d expression in renal allograft biopsies.
    Meehan SM; Kremer J; Ali FN; Curley J; Marino S; Chang A; Kadambi PV
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):395-403. PubMed ID: 20966124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of tacrolimus-associated thrombotic microangiopathy after ABO-blood-type-incompatible renal transplantation.
    Takeda A; Ohtsuka Y; Horike K; Inaguma D; Goto N; Watarai Y; Uchida K; Morozumi K
    Clin Transplant; 2011 Jul; 25 Suppl 23():15-8. PubMed ID: 21623908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of progressive thrombotic microangiopathy after ABO-incompatible renal transplantation.
    Miura M; Fujita H; Suzuki A; Kubota KC; Fukasawa Y; Shimoda N; Tsuchihashi S; Tamaki T
    Clin Transplant; 2011 Jul; 25 Suppl 23():19-22. PubMed ID: 21623909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of transplant glomerulopathy and thrombotic microangiopathy in kidney transplant biopsies.
    Sreedharanunni S; Joshi K; Duggal R; Nada R; Minz M; Sakhuja V
    Transpl Int; 2014 Aug; 27(8):784-92. PubMed ID: 24684170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo thrombotic microangiopathy after kidney transplantation.
    Garg N; Rennke HG; Pavlakis M; Zandi-Nejad K
    Transplant Rev (Orlando); 2018 Jan; 32(1):58-68. PubMed ID: 29157988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of early pancreas graft failure via antibody-mediated rejection: single-center experience with 256 pancreas transplantations.
    de Kort H; Mallat MJ; van Kooten C; de Heer E; Brand-Schaaf SH; van der Wal AM; Roufosse C; Roelen DL; Bruijn JA; Claas FH; de Fijter JW; Bajema IM
    Am J Transplant; 2014 Apr; 14(4):936-42. PubMed ID: 24712331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.